Results 231 to 240 of about 16,187,582 (338)

Production Methods, Biological Activity and Potential Application Prospects of Astaxanthin. [PDF]

Foods
Ren F, Rao C, Xiang Q, Wen J, Dai Q, Li H, Liang J, Chen Y, Peng C.   +8 more
europepmc   +1 more source

Selective inactivation of biological activity of myxoviruses by glutaraldehyde [PDF]

, 1966
Herbert A. Blough
openalex   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Nitrogen-containing secondary metabolites from Meliaceae Family and their biological activity: a review. [PDF]

Nat Prod Bioprospect
Martiningsih NW, Sinaga SE, Safriansyah W, Supratman U, Harneti D.   +4 more
europepmc   +1 more source

Actinomycin Analogues Containing Pipecolic Acid: Relationship of Structure to Biological Activity [PDF]

, 1968
Joseph V. Formica, Aaron J. Shatkin, Edward Katz   +2 more
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Structural substitutions on the methoxybenzene ring retain the biological activity of the zaxinone mimics MiZax3. [PDF]

Front Plant Sci
Wang JY, Jamil M, Tareq Berqdar LM, Takahashi I, Ota T, Asami T, Al-Babili S.   +6 more
europepmc   +1 more source

Studies on the chemical nature of the substance inducing transformation of pneumococcal types; effect of desoxyribonuclease on the biological activity of the transforming substance.

, 1946
Maclyn McCarty, Oswald T. Avery
openalex  

Importance of Amino Acid Side Groups for Biologic Activity of Angiotensin II [PDF]

, 1962
F. Merlin Bumpus, Robert R. Smeby
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source